# Transplantation of Umbilical Cord Blood Following Chemotherapy for Blood Cancers

> **NCT00539656** · PHASE1,PHASE2 · TERMINATED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins** · enrollment: 3 (actual)

## Conditions studied

- Acute Myeloid Leukemia
- Leukemia, Lymphoblastic, Acute
- Leukemia, Bilineage, Acute
- Leukemia, Myeloid, Chronic

## Interventions

- **BIOLOGICAL:** Ex vivo expansion of cord blood

## Key facts

- **NCT ID:** NCT00539656
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-12-20
- **Primary completion:** 2009-10-20
- **Final completion:** 2009-10-20
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** The manufacturer discontinued necessary reagents.
- **Last updated:** 2020-02-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00539656

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00539656, "Transplantation of Umbilical Cord Blood Following Chemotherapy for Blood Cancers". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00539656. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*